Valvular & structural heart disease
Incremental cost of complications after transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) in contemporary clinical practice
Authors' conclusion
This study provides contemporary data on the incremental costs of specific peri-procedural complications associated with TAVR and SAVR.
Study context
- Population
- Medicare beneficiaries receiving SAVR or TAVR in the US, fiscal year 2021
- Exposure
- Complicated vs uncomplicated index hospitalisation after TAVR and SAVR
- Outcome
- Incremental cost and LOS for each complication
Methodological detailsMedicare 100% standard analytic file, multivariable analyses
- Medicare 100% standard analytic file
- Multivariable analyses
Main finding
As reported in the abstract
Index hospitalisation cost and LOS
| Group | Uncomplicated cost | Uncomplicated length of stay (LOS) | Cost with any complication | LOS with any complication | Highest incremental cost (prolonged ventilation) | Highest attributable cost (pacemaker implantation) | Highest attributable cost (prolonged ventilation) |
|---|---|---|---|---|---|---|---|
| TAVR | $46,257 | 2.2 days | $66,601 | 5.9 days | $55,742 | $1,270 | |
| SAVR | $58,488 | 8.1 days | $88,900 | 13.4 days | $69,728 | $2,580 |
Uncomplicated cost
TAVR$46,257
SAVR$58,488
Uncomplicated length of stay (LOS)
TAVR2.2 days
SAVR8.1 days
Cost with any complication
TAVR$66,601
SAVR$88,900
LOS with any complication
TAVR5.9 days
SAVR13.4 days
Highest incremental cost (prolonged ventilation)
TAVR$55,742
SAVR$69,728
Highest attributable cost (pacemaker implantation)
TAVR$1,270
SAVR— not stated in the abstract
Highest attributable cost (prolonged ventilation)
TAVR— not stated in the abstract
SAVR$2,580
Observational data: associations, not effects.
Original publication
Incremental cost of complications after TAVR and SAVR in contemporary clinical practice. Am Heart J. Published 12 July 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →